Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate-specific antigen.

M K Brawer1

  • 1Northwest Prostate Institute, Northwest Hospital, Seattle, Washington 98133, USA. mbrawer@nwhsea.org

Seminars in Surgical Oncology
|January 5, 2000
PubMed
Summary
This summary is machine-generated.

Prostate-specific antigen (PSA) is crucial for early prostate cancer detection. New molecular forms of free and complex PSA promise to improve test specificity, reducing false positives.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Evidence: Non-metastatic prostate cancer.

The Western journal of medicine·2008
Same author

Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience.

Reviews in urology·2006
Same author

Letter from the editors of reviews in urology.

Reviews in urology·2006
Same author

Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer.

Reviews in urology·2006
Same author

Readership survey: reviews in urology.

Reviews in urology·2006
Same author

New urologic strategies explored at jackson hole: highlights from the 20th annual jackson hole urologic conference january 22-28, 2000, jackson hole, wyo.

Reviews in urology·2006
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Area of Science:

  • Oncology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Prostate-specific antigen (PSA) has transformed prostate cancer diagnosis and management.
  • Early immunoassays have advanced significantly.
  • PSA is vital for staging and monitoring, but most impactful in early detection.

Purpose of the Study:

  • To review the current status of PSA in prostate cancer diagnostics.
  • To emphasize methods for enhancing PSA specificity in early detection.
  • To discuss applications of improved PSA testing.

Main Methods:

  • Literature review of salient studies on PSA and its molecular forms.
  • Analysis of current PSA testing methodologies.
  • Evaluation of strategies to enhance PSA specificity.

Related Experiment Videos

Main Results:

  • PSA is the most significant tumor marker for evaluating potential prostate cancer.
  • Recognizing molecular forms of free PSA and complex PSA shows promise for enhancing specificity.
  • Improved specificity is expected to reduce false-positive PSA test results.

Conclusions:

  • PSA remains indispensable for prostate cancer evaluation.
  • Enhancing PSA specificity is a critical need in early detection.
  • Understanding molecular PSA forms offers a promising path to more accurate diagnostics.